Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
113.56
-0.45 (-0.39%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
2 Excellent Dividend Stocks to Buy With Less Than $200
September 28, 2024
Abbott Laboratories and Johnson & Johnson both have raised their dividends annually for more than 50 years.
Via
The Motley Fool
Navigating 6 Analyst Ratings For Abbott Laboratories
September 26, 2024
Via
Benzinga
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
September 25, 2024
These dividend players could lift your portfolio no matter what the market is doing.
Via
The Motley Fool
Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst
September 19, 2024
Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech growth and attractive valuation.
Via
Benzinga
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
September 19, 2024
Via
Benzinga
20 S&P 500 Stocks That Move The Most When The Fed Starts Cutting Interest Rates
September 18, 2024
Investors are anticipating the first cut to the federal funds rate in over four years at the September FOMC meeting. The market is divided on the magnitude of the cut, which could trigger significant...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
September 16, 2024
The dividend growth powerhouse is turning the corner.
Via
The Motley Fool
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?
September 16, 2024
The company continues to flex its innovative muscles.
Via
The Motley Fool
3 Stocks to Buy and Hold Forever
September 14, 2024
These stocks are built for the long run.
Via
The Motley Fool
3 Ultra-Safe Dividend Stocks for Retirees to Buy and Hold
September 13, 2024
These stocks have increased their payouts for decades.
Via
The Motley Fool
Why ABBOTT LABORATORIES (NYSE:ABT) should be investigated by quality investors.
September 11, 2024
Is ABBOTT LABORATORIES (NYSE:ABT) a Strong Candidate for Quality Investing?
Via
Chartmill
2 Stocks That Are Passive Income Machines to Buy and Hold Forever
September 11, 2024
You can take these dividends straight to the bank.
Via
The Motley Fool
Looking Into Abbott Laboratories's Recent Short Interest
August 29, 2024
Via
Benzinga
Abbott Laboratories Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
August 22, 2024
Via
Benzinga
Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System
September 05, 2024
Abbott recalls some FreeStyle Libre 3 sensors due to incorrect glucose readings, risking severe health issues.
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Abbott's 'Transformative' Move And Answer To Dexcom's Newest Device
September 05, 2024
The companies are now duking it out for a new population of CGM users.
Via
Investor's Business Daily
Patchy But Still Bullish
September 02, 2024
Two weeks ago we turned to a more bullish stance, which has proved to be correct, though we still await the explosive movement out of these consolidations.
Via
Talk Markets
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
August 30, 2024
These three have secure core businesses, plus multiple paths to grow.
Via
The Motley Fool
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
August 26, 2024
Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing...
Via
Benzinga
Dexcom's Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients
August 26, 2024
DexCom's Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor, is now available without a prescription. Designed for people with Type 2 diabetes and prediabetes, Stelo...
Via
Benzinga
Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back?
August 26, 2024
The company is upbeat on its upcoming Stelo launch. The CGM is geared to people who don't use insulin.
Via
Investor's Business Daily
This Is Great News for Medtronic, but Is It Time to Buy the Stock?
August 26, 2024
This MedTech leader is back on track with profitable growth.
Via
The Motley Fool
Donald Trump Owns These 21 Dividend Kings. Should You?
August 26, 2024
Some of Trump's Dividend Kings deserve a crown more than others.
Via
The Motley Fool
Topics
Government
Exposures
Political
3 Unstoppable Dividend Stocks to Buy Right Now
August 25, 2024
These stocks are the A-team for income investors.
Via
The Motley Fool
Abbott Laboratories, Nu Holdings And More On CNBC's 'Final Trades'
August 22, 2024
Abbott Laboratories has a strong pipeline and the stock is starting to move, according to Karen Firestone of Aureus Asset Management.
Via
Benzinga
Looking for Safe Dividend Income? These 3 Stocks Have Rock-Solid Payouts.
August 17, 2024
These stocks pay above-average yields, and their dividend income could rise higher in the future.
Via
The Motley Fool
Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108?
August 12, 2024
An unexpected diabetes partnership with Medtronic bodes well for Abbott's biggest growth driver.
Via
The Motley Fool
3 Stocks Retirees Should Absolutely Love
August 10, 2024
All of these stocks can provide steady income to retired investors.
Via
The Motley Fool
Chips, Glorious Chips!
August 07, 2024
Someone's gotta make 'em, and someone's gotta buy 'em.
Via
The Motley Fool
3 Dividend Growth Stocks to Buy Hand Over Fist in August
August 07, 2024
There are blue-chip bargains paying large and growing dividends in the healthcare space.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.